Medicinal cannabis has become an area of growing scientific and clinical interest. Researchers continue to investigate cannabinoids, cannabinoid receptors, signalling pathways and the broader endocannabinoid system to better understand how these biological systems function within the human body.
This page provides educational information regarding current scientific understanding of medicinal cannabis, cannabinoids and the endocannabinoid system. Readers seeking organisational information may also review About MOCA Health: Our Commitment to Quality and Compliance.
Cannabinoids are naturally occurring compounds associated with the cannabis plant. More than one hundred cannabinoids have been identified, although CBD (cannabidiol) and THC (tetrahydrocannabinol) remain among the most widely studied.
Researchers continue to investigate how cannabinoids interact with biological signalling systems and the endocannabinoid system.
Individuals seeking additional botanical information may also review Overview of Cannabis Flowers and Health Attributes.
The endocannabinoid system (ECS) is a biological signalling network identified by researchers in the late twentieth century.
Scientific literature commonly describes three broad components:
Endocannabinoids
Cannabinoid receptors
Metabolic enzymes
Researchers continue to investigate the role of these components in human physiology and biological regulation.
Additional educational information is available through Educational Resources: Learn More About Medical Cannabis.
Current research commonly refers to two major receptor groups:
CB1 receptors are found predominantly within the central nervous system and continue to be studied for their role in neurological signalling pathways.
CB2 receptors are found more broadly throughout peripheral tissues and immune-related systems and remain an ongoing area of scientific investigation.
Researchers continue exploring how receptor systems interact with naturally occurring endocannabinoids and plant-derived cannabinoids.
Medicinal cannabis research remains an evolving field involving:
cannabinoid science
receptor biology
pharmacology
neuroscience
immunology
healthcare outcomes research
As scientific understanding develops, researchers continue investigating the relationships between cannabinoids, biological systems and healthcare applications.
Readers interested in production and quality systems may also review Our Cannabis Production Process: From Seed to Supply.
Scientific research should be considered separately from healthcare decision-making.
Where medicinal cannabis is discussed within healthcare settings, clinical assessment remains the responsibility of appropriately qualified healthcare practitioners.
Individuals interested in understanding healthcare access pathways may review:
How MOCA Health Works: Streamlined Access to Medical Cannabis
Telehealth Consultations: Accessing Cannabis Care Anywhere in Australia
Healthcare providers seeking professional information may also review For Healthcare Providers: Partnering with MOCA Health.
Australia's medicinal cannabis sector operates within a regulated framework involving healthcare practitioners, manufacturers, distributors and regulatory authorities.
Further information regarding compliance and governance systems is available through:
The scientific understanding of medicinal cannabis continues to evolve as researchers investigate cannabinoids, biological signalling systems and healthcare applications.
Individuals seeking broader educational information may also review:
For information regarding practitioner-led healthcare pathways, visit Get In Touch: Start Your Journey or Speak With Practitioner.